深圳欣博盛生物科技有限公司 a1

TNFRSF9 Recombinant Protein
品牌:ProSci LLC
货号:96-004 规格:0.1 mg 目录价:¥9038.25
产品详情
* 以下信息仅供参考,详情请以原厂网站为准
产品名称:
TNFRSF9 Recombinant Protein
别名:
TNFRSF9, 4-1BB, CD137, CDw137, ILA
实验应用:
WB
表达系统:
HEK293 cells
保存温度:
Lyophilized Protein should be stored at -20˚C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20˚C or -70˚C. Avoid repeated freeze-thaw cycles.
运输温度:
Blue Ice
产品形式:
Lyophilized
存储溶液:
50 mM tris, 100 mM glycine, pH7.5.
产地:
美国
生产商:
Prosci
功能与背景:
4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.
纯度:
>95% as determined by SDS-PAGE.
生物活性:
Measured by its binding ability in a functional ELISA. When Recombinant Human 4-1BB Protein, With C-Fc Tag is Immobilized at 10 ng/mL (100 μl/well), Recombinant Human 4-1BB Ligand produces 50% optimal binding response with a concentration range of 0. 75 – 3. 0 ng/mL.
Accession #:
NP_001552.2
在线留言
咨询类型
联系人
*
联系方式
*
单位名称
*
咨询内容
*
复制QQ号成功,请打开QQ后添加好友进行咨询